Overview

• The U.S. obesity rate fell by about two percentage points between 2020 and 2023, according to recent data.
• Semaglutide drugs, including Ozempic and Wegovy, are believed to play a key role in this decline by suppressing appetite.
• Prescriptions for these weight-loss drugs surged significantly during the period of declining obesity rates.
• The decline in obesity is more pronounced among college graduates, who are more likely to use these medications.
• Despite their benefits, these drugs have sparked controversy over their use as an 'easy way out' compared to traditional weight loss methods.